Below are the most recent publications written about "Antigens, Protozoan" by people in Profiles.
-
Schaefer JJ, White HA, Schaaf SL, Mohammed HO, Wade SE. Modification of a commercial Toxoplasma gondii immunoglobulin G enzyme-linked immunosorbent assay for use in multiple animal species. J Vet Diagn Invest. 2011 Mar; 23(2):297-301.
-
Pandey JP, Morais CG, Fontes CJ, Braga EM. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1. Malar J. 2010 Aug 09; 9:229.
-
Giha HA, Nasr A, Iriemenam NC, Arnot D, Troye-Blomberg M, Theander TG, Berzins K, ElGhazali G, Pandey JP. Antigen-specific influence of GM/KM allotypes on IgG isotypes and association of GM allotypes with susceptibility to Plasmodium falciparum malaria. Malar J. 2009 Dec 22; 8:306.
-
Welch RJ, Anderson BL, Litwin CM. Rapid immunochromatographic strip test for detection of anti-K39 immunoglobulin G antibodies for diagnosis of visceral leishmaniasis. Clin Vaccine Immunol. 2008 Sep; 15(9):1483-4.
-
Guglietta S, Beghetto E, Spadoni A, Buffolano W, Del Porto P, Gargano N. Age-dependent impairment of functional helper T cell responses to immunodominant epitopes of Toxoplasma gondii antigens in congenitally infected individuals. Microbes Infect. 2007 Feb; 9(2):127-33.
-
Beghetto E, Nielsen HV, Del Porto P, Buffolano W, Guglietta S, Felici F, Petersen E, Gargano N. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J Infect Dis. 2005 Feb 15; 191(4):637-45.
-
Di Cristina M, Del Porto P, Buffolano W, Beghetto E, Spadoni A, Guglietta S, Piccolella E, Felici F, Gargano N. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes Infect. 2004 Feb; 6(2):164-71.
-
Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis. 1998 Jun; 177(6):1664-73.
-
Le TP, Church LW, Corradin G, Hunter RL, Charoenvit Y, Wang R, de la Vega P, Sacci J, Ballou WR, Kolodny N, Kitov S, Glenn GM, Richards RL, Alving CR, Hoffman SL. Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants. Vaccine. 1998 Jan-Feb; 16(2-3):305-12.
-
Troye-Blomberg M, Olerup O, Perlmann H, Larsson A, Elghazali G, Fogdell A, Jepsen A, Lepers JP, Pandey JP, Grunewald J, et al. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA. Behring Inst Mitt. 1994 Dec; (95):97-105.